Cargando…
HIV-1 Vpr antagonizes innate immune activation by targeting karyopherin-mediated NF-κB/IRF3 nuclear transport
HIV-1 must replicate in cells that are equipped to defend themselves from infection through intracellular innate immune systems. HIV-1 evades innate immune sensing through encapsidated DNA synthesis and encodes accessory genes that antagonize specific antiviral effectors. Here, we show that both par...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
eLife Sciences Publications, Ltd
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7759385/ https://www.ncbi.nlm.nih.gov/pubmed/33300875 http://dx.doi.org/10.7554/eLife.60821 |
_version_ | 1783627100830302208 |
---|---|
author | Khan, Hataf Sumner, Rebecca P Rasaiyaah, Jane Tan, Choon Ping Rodriguez-Plata, Maria Teresa Van Tulleken, Chris Fink, Douglas Zuliani-Alvarez, Lorena Thorne, Lucy Stirling, David Milne, Richard SB Towers, Greg J |
author_facet | Khan, Hataf Sumner, Rebecca P Rasaiyaah, Jane Tan, Choon Ping Rodriguez-Plata, Maria Teresa Van Tulleken, Chris Fink, Douglas Zuliani-Alvarez, Lorena Thorne, Lucy Stirling, David Milne, Richard SB Towers, Greg J |
author_sort | Khan, Hataf |
collection | PubMed |
description | HIV-1 must replicate in cells that are equipped to defend themselves from infection through intracellular innate immune systems. HIV-1 evades innate immune sensing through encapsidated DNA synthesis and encodes accessory genes that antagonize specific antiviral effectors. Here, we show that both particle associated, and expressed HIV-1 Vpr, antagonize the stimulatory effect of a variety of pathogen associated molecular patterns by inhibiting IRF3 and NF-κB nuclear transport. Phosphorylation of IRF3 at S396, but not S386, was also inhibited. We propose that, rather than promoting HIV-1 nuclear import, Vpr interacts with karyopherins to disturb their import of IRF3 and NF-κB to promote replication in macrophages. Concordantly, we demonstrate Vpr-dependent rescue of HIV-1 replication in human macrophages from inhibition by cGAMP, the product of activated cGAS. We propose a model that unifies Vpr manipulation of nuclear import and inhibition of innate immune activation to promote HIV-1 replication and transmission. |
format | Online Article Text |
id | pubmed-7759385 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | eLife Sciences Publications, Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-77593852020-12-28 HIV-1 Vpr antagonizes innate immune activation by targeting karyopherin-mediated NF-κB/IRF3 nuclear transport Khan, Hataf Sumner, Rebecca P Rasaiyaah, Jane Tan, Choon Ping Rodriguez-Plata, Maria Teresa Van Tulleken, Chris Fink, Douglas Zuliani-Alvarez, Lorena Thorne, Lucy Stirling, David Milne, Richard SB Towers, Greg J eLife Microbiology and Infectious Disease HIV-1 must replicate in cells that are equipped to defend themselves from infection through intracellular innate immune systems. HIV-1 evades innate immune sensing through encapsidated DNA synthesis and encodes accessory genes that antagonize specific antiviral effectors. Here, we show that both particle associated, and expressed HIV-1 Vpr, antagonize the stimulatory effect of a variety of pathogen associated molecular patterns by inhibiting IRF3 and NF-κB nuclear transport. Phosphorylation of IRF3 at S396, but not S386, was also inhibited. We propose that, rather than promoting HIV-1 nuclear import, Vpr interacts with karyopherins to disturb their import of IRF3 and NF-κB to promote replication in macrophages. Concordantly, we demonstrate Vpr-dependent rescue of HIV-1 replication in human macrophages from inhibition by cGAMP, the product of activated cGAS. We propose a model that unifies Vpr manipulation of nuclear import and inhibition of innate immune activation to promote HIV-1 replication and transmission. eLife Sciences Publications, Ltd 2020-12-10 /pmc/articles/PMC7759385/ /pubmed/33300875 http://dx.doi.org/10.7554/eLife.60821 Text en © 2020, Khan et al http://creativecommons.org/licenses/by/4.0/ http://creativecommons.org/licenses/by/4.0/This article is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use and redistribution provided that the original author and source are credited. |
spellingShingle | Microbiology and Infectious Disease Khan, Hataf Sumner, Rebecca P Rasaiyaah, Jane Tan, Choon Ping Rodriguez-Plata, Maria Teresa Van Tulleken, Chris Fink, Douglas Zuliani-Alvarez, Lorena Thorne, Lucy Stirling, David Milne, Richard SB Towers, Greg J HIV-1 Vpr antagonizes innate immune activation by targeting karyopherin-mediated NF-κB/IRF3 nuclear transport |
title | HIV-1 Vpr antagonizes innate immune activation by targeting karyopherin-mediated NF-κB/IRF3 nuclear transport |
title_full | HIV-1 Vpr antagonizes innate immune activation by targeting karyopherin-mediated NF-κB/IRF3 nuclear transport |
title_fullStr | HIV-1 Vpr antagonizes innate immune activation by targeting karyopherin-mediated NF-κB/IRF3 nuclear transport |
title_full_unstemmed | HIV-1 Vpr antagonizes innate immune activation by targeting karyopherin-mediated NF-κB/IRF3 nuclear transport |
title_short | HIV-1 Vpr antagonizes innate immune activation by targeting karyopherin-mediated NF-κB/IRF3 nuclear transport |
title_sort | hiv-1 vpr antagonizes innate immune activation by targeting karyopherin-mediated nf-κb/irf3 nuclear transport |
topic | Microbiology and Infectious Disease |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7759385/ https://www.ncbi.nlm.nih.gov/pubmed/33300875 http://dx.doi.org/10.7554/eLife.60821 |
work_keys_str_mv | AT khanhataf hiv1vprantagonizesinnateimmuneactivationbytargetingkaryopherinmediatednfkbirf3nucleartransport AT sumnerrebeccap hiv1vprantagonizesinnateimmuneactivationbytargetingkaryopherinmediatednfkbirf3nucleartransport AT rasaiyaahjane hiv1vprantagonizesinnateimmuneactivationbytargetingkaryopherinmediatednfkbirf3nucleartransport AT tanchoonping hiv1vprantagonizesinnateimmuneactivationbytargetingkaryopherinmediatednfkbirf3nucleartransport AT rodriguezplatamariateresa hiv1vprantagonizesinnateimmuneactivationbytargetingkaryopherinmediatednfkbirf3nucleartransport AT vantullekenchris hiv1vprantagonizesinnateimmuneactivationbytargetingkaryopherinmediatednfkbirf3nucleartransport AT finkdouglas hiv1vprantagonizesinnateimmuneactivationbytargetingkaryopherinmediatednfkbirf3nucleartransport AT zulianialvarezlorena hiv1vprantagonizesinnateimmuneactivationbytargetingkaryopherinmediatednfkbirf3nucleartransport AT thornelucy hiv1vprantagonizesinnateimmuneactivationbytargetingkaryopherinmediatednfkbirf3nucleartransport AT stirlingdavid hiv1vprantagonizesinnateimmuneactivationbytargetingkaryopherinmediatednfkbirf3nucleartransport AT milnerichardsb hiv1vprantagonizesinnateimmuneactivationbytargetingkaryopherinmediatednfkbirf3nucleartransport AT towersgregj hiv1vprantagonizesinnateimmuneactivationbytargetingkaryopherinmediatednfkbirf3nucleartransport |